What We're Reading: Page 116
Industry reads hand-picked by our editors
Dec 14, 2022
-
Fierce Biotech
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
-
MIT Technology Review
Neuroscientists have created a mood decoder that can measure depression
-
Bloomberg
Long Covid’s Effects Go Beyond Respiratory Issues
Dec 13, 2022
Dec 12, 2022
-
The Wall Street Journal
The Biotech Takeout Menu Gets Pricier
-
Axios
The growing market for weight loss drugs
-
Financial Times
Immunocore’s Bahija Jallal: ‘There was fantastic science, but without financing, we could not go anywhere’
Dec 09, 2022
-
The Wall Street Journal
Mark Cuban Has a New Job: Working at an Online Discount Pharmacy
-
Reuters
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
-
The New York Times
The F.T.C.’s Bet on Rewriting Antitrust by Taking on Microsoft
-
MIT Technology Review
DNA that was frozen for 2 million years has been sequenced
Dec 08, 2022
-
NPR
Is lecanemab the Alzheimer’s drug that will finally make a difference?
-
The Wall Street Journal
How AI That Powers Chatbots and Search Queries Could Discover New Drugs
-
Boston Business Journal
Tech, biotech companies have laid off thousands in Mass. in 2022
-
Reuters
Takeda’s dengue vaccine wins EU approval
Dec 07, 2022
Dec 06, 2022
-
The Wall Street Journal
FDA Takes Tougher Line on Fast-Tracked Drugs
-
The New York Times
A Promising Trial Targets a Genetic Risk for Alzheimer’s
-
Reuters
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
-
Science
Uganda’s disappearing Ebola outbreak challenges vaccine testing
Previous
